Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rieko Kaira"'
Autor:
Akira Ono, Asuka Tsuya, Toshiaki Takahashi, Kazuhisa Takahashi, Hideyuki Harada, Yoko Nakasu, Rieko Kaira, Yukiko Nakamura, Nobuyuki Yamamoto, Masahiro Endo, Hirotsugu Kenmotsu, Koichi Mitsuya, Takehito Shukuya, Tateaki Naito, Haruyasu Murakami
Publikováno v:
Lung Cancer. 74:457-461
Introduction Based on previous reports, patients who experience isolated central nervous system (CNS) failure may not have systemic acquired resistance to EGFR-TKI therapy. However, because there are few articles that have reported on the clinical ef
Autor:
Kazuo Nakagawa, Satoru Miura, Kyoichi Kaira, Masakuni Serizawa, Toshiaki Takahashi, Nobuyuki Yamamoto, Takehiro Okumura, Takashi Nakajima, Yasuhisa Ohde, Haruhiko Kondo, Rieko Kaira, Masahiro Endo, Haruyasu Murakami, Yasuhiro Koh, Tateaki Naito, Masato Abe
Publikováno v:
Journal of Thoracic Oncology. 6(3):606-613
Background: We investigated the clinical significance of excision repair cross-complementation group 1 (ERCC1), breast cancer susceptibility 1 (BRCA1), and class III β-tubulin (TUBB3) expression in thymic epithelial tumors. Method: Fifty-six patient
Autor:
Tateaki Naito, Hirotsugu Kenmotsu, Rieko Kaira, Takehito Shukuya, Kazuhisa Takahashi, Asuka Tsuya, Kyoichi Kaira, Toshiaki Takahashi, Akira Ono, Yukiko Nakamura, Nobuyuki Yamamoto, Masahiro Endo, Haruyasu Murakami
Publikováno v:
Cancer Science. 102:1032-1037
The efficacy of gefitinib for patients with non-adenocarcinoma non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations is unclear, because only a small percentage of patients enrolled in the clinical trials to e
Autor:
Toshiaki Takahashi, Asuka Tsuya, Nobuyuki Yamamoto, Tateaki Naito, Kyoichi Kaira, Yukiko Nakamura, Haruyasu Murakami, Rieko Kaira, Masahiro Endo
Publikováno v:
International Journal of Clinical Oncology. 15:484-488
Elevated levels of N-telopeptide of type I collagen (NTX) are associated with skeletal-related events and death. However, it is unclear whether NTX is useful for monitoring therapeutic response in non-small cell lung cancer (NSCLC) patients with bone
Autor:
Akira, Ono, Tateaki, Naito, Haruyasu, Murakami, Toshiaki, Takahashi, Yukiko, Nakamura, Asuka, Tsuya, Kyoichi, Kaira, Satoshi, Igawa, Takehito, Shukuya, Takehiro, Shukuya, Akihiro, Tamiya, Rieko, Kaira, Masahiro, Endo, Nobuyuki, Yamamoto
Publikováno v:
International Journal of Clinical Oncology. 15:161-165
No investigation of S-1 monotherapy in previously treated advanced non-small-cell lung cancer (NSCLC) patients has yet been reported. We conducted a retrospective study to evaluate the efficacy and tolerability of S-1 in patients with failure of seco
Autor:
Yukiko Nakamura, Satoru Miura, Hiroaki Akamatsu, Hirotsugu Kenmotsu, Haruyasu Murakami, Nobuyuki Yamamoto, Toshiaki Takahashi, Rieko Kaira, Tateaki Naito, Masahiro Endo, Kyoichi Kaira, Akira Ono, Takehito Shukuya, Asuka Tsuya
Publikováno v:
Investigational new drugs. 33(3)
Background Central nervous system (CNS) metastases caused by small-cell lung cancer (SCLC) are incurable and therefore fatal. Although such metastases are usually treated with chemotherapy or radiotherapy, their sensitivity to these treatment measure
Autor:
Yukiko Nakamura, Masakuni Serizawa, Masato Abe, Kazuo Nakagawa, Haruyasu Murakami, Satoru Miura, Yasuhisa Ohde, Yasuhiro Koh, Masahiro Endo, Toshiaki Takahashi, Asuka Tsuya, Tateaki Naito, Rieko Kaira, Haruhiko Kondo, Kyoichi Kaira, Takehiro Okumura, Nobuyuki Yamamoto, Takashi Nakajima
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 74(3)
Background It remains unclear whether thymidylate synthase (TS), orotate phosphoribosyltransferase (OPRT) and dihydropyrimidine dehydrogenase (DPD) expressions are associated with the pathogenesis of thymic epithelial tumors. Therefore, we investigat
Autor:
Yukiko Nakamura, Madoka Kimura, Hiroaki Akamatsu, Rieko Kaira, Tateaki Naito, Masahiro Endo, Nobuyuki Yamamoto, Kyoichi Kaira, Asuka Tsuya, Haruyasu Murakami, Toshiaki Takahashi, Akira Ono, Satoru Miura
Publikováno v:
Annals of nuclear medicine. 25(4)
Positron emission tomography (PET) with fluorine-18-fluorodeoxyglucose ((18)F-FDG) has been studied in thymic epithelial tumors. We evaluated the usefulness of (18)F-FDG PET for monitoring after treatment in unresectable thymic epithelial tumors.Twel
Autor:
Eriko Ayabe, Haruyasu Murakami, Asuka Tsuya, Rieko Kaira, Rai Shimoyama, Satoshi Igawa, Toshiaki Takahashi, Yukiko Nakamura, Nobuyuki Yamamoto, Tateaki Naito, Akira Ono, Masahiro Endo, Takehito Shukuya, Kyoichi Kaira
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 68(1)
Purpose The use of erlotinib after gefitinib failure in patients with non-small cell lung cancer (NSCLC) is not clearly clarified in clinical practice. We sought to compile the available clinical reports to better understand the effectiveness of erlo
Autor:
Masahiro Endo, Haruyasu Murakami, Nobuyuki Yamamoto, Tateaki Naito, Toshiaki Takahashi, Rieko Kaira, Kyoichi Kaira, Asuka Tsuya, Yukiko Nakamura, Takehito Shukuya, Akira Ono, Hirotsugu Kenmotsu
Publikováno v:
World Journal of Respirology. 3:110
Long-term survival of more than 3 years among patients with advanced non-small cell lung cancer treated with chemotherapy